p16INK4a
January 24, 2020IKK
January 24, 2020- … -1 CONVEYS TEMOZOLOMIDE RESISTANCE BY THE INHIBITING DNA DAMAGE RESPONSE PATHWAY THROUGH THE POLYCOMB REPRESSOR Bmi-1
- … and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV)-mediated Bmi-1 interference driven by Bmi-1 promoter for gastric …
- … butyrate inhibits migration and induces AMPK‐mTOR pathway‐dependent autophagy and ROS‐mediated apoptosis via the miR‐139‐5p/Bmi‐1 axis in human …
- … following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of Bmi-1 and immune responses to Bmi-1 …
- … inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
- … regulates paclitaxel resistance of ovarian cancer cells-a potential of miR-194 by attenuating paclitaxel resistance through the down-regulation of oncogene Bmi-1
- … the centromere complex from HeLa interphase cells: UV‐damaged DNA binding protein 1 (DDB‐1) is a component of the CEN‐complex, while BMI‐1 is transiently co …
- … the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting Bmi-1
- … with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by Bmi-1
- 15 Evaluation of Expression of the Bmi-1 Stem Cell Marker in Sinonasal Melanomas and Its Correlation With the Expression of Cell Cycle Proteins
- 40. Bmi-1 GENE SILENCING INFLUENCES CELL ADHESION AND INVASIVE PROPERTIES OF MEDULLOBLASTOMA CELLS VIA INHIBITION OF BMP PATHWAY
- A death from cancer signature: Microarray analysis identifies the 11-gene Bmi-1-pathway signature predicting therapy failure and short survival of patients diagnosed …
- A novel Bmi-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
- A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1
- A novel pathway involving Tcf-driven Bcl2 under regulation of Bmi-1 stem cell factor: Role in chemoresistance
- A regulatory Bmi 1/let‐7i/ERK 3 pathway controls the motility of head and neck cancer cells
- A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma
- Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genes
- Abstract A130: Targeting Bmi-1 by the novel Bmi-1 inhibitor PTC596 in acute leukemia
- Abstract A261: NPV-LDE-225 (Erismodegib) inhibits human prostate cancer stem cell growth in NOD/SCID IL2γnull mice by regulating Bmi-1 and microRNA-128.
- Abstract LB-234: Bcl-2, a novel target of Bmi-1 (the stem cell associated factor), induced Wnt signaling: Implications on prostate cancer
- Abstract# 1073: Targeting Bmi-1 in prostate cancer stem cells
- Abstract# 2185: Ewing family tumors that do not over-express Bmi-1 are a distinct subclass that arise from alternate mechanisms of molecular transformation
- Abstract# 2564: Relationship of smoothened (SMO) and Bmi-1 expression to progression free survival and overall survival in patients with resected non-small cell lung …
- Abstract# 5604: Bmi-1 protects human oral epithelial cells from ionizing radiation
- Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of Bmi-1, TIM-3 and CLL-1
- Adenovirus-delivered Bmi-1 shRNA
- Affect of All-trans Retinoic Acid on Expression of Bmi-1 in A431 Cell Line [J]
- Alexa Fluor® 488 Mouse Anti-Human Bmi-1
- Alexa Fluor® 647 Mouse Anti-Human Bmi-1
- Amplification and construction of its sense and antisense eukaryotic expression vector of transcriptional repressor Bmi-1 gene
- An old player on a new playground: Bmi-1 as a regulator of prostate stem cells
- Anti-aging and anti-osteoporosis effects of green teen polyphenol in a premature aging model of Bmi-1 knockout mice
- Anti-aging effect of transplanted amniotic membrane mesenchymal stem cells in a premature aging model of Bmi-1 deficiency
- Anti-proliferation effect of Bmi-1 in U937 cells with siRNA
- Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549
- Association between Bmi-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in …
- Association between the Polycomb Group (PcG) Bmi-1 Gene Expression and Outcome in Chronic Myeloid Leukemia (CML) Patients Receiving Allogeneic Stem Cell …
- Association of ATM and BMI‐1 genetic variation with breast cancer risk in Han Chinese
- Association of Bmi-1 and p16 as prognostic factors for head and neck carcinomas
- Association of Bmi-1 expression with clinicopathological features and prognosis of colorectal cancer
- Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma
- Association of Elevated Peripheral Blood Micronucleus Frequency and Bmi-1 mRNA Expression with Metastasis in Iranian Breast Cancer Patients
- Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma
- Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression
- B-Cell Lymphoma Cells Overexpressing Bmi-1 Are Correlated with Drug Resistance through Enhanced Expression of Survivin and Are Effectively Eliminated by T …
- Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice
- Bmi 1 is downregulated by the natural compound curcumin, but not by bisdemethoxycurcumin and dimethoxycurcumin
- BMI is an important driver of beta-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.
- Bmi-1 absence causes premature brain degeneration
- Bmi-1 activation is crucial in hTERT-induced epithelial–mesenchymal transition of oral epithelial cells
- Bmi-1 and homologous recombination markers in human breast cancer
- Bmi-1 and survivin expression with clinicopathological correlation and prognostic impact in B and T/NK-cell non-Hodgkin lymphoma
- Bmi-1 as A Molecular Marker for Prognosis of Pediatric ALL
- Bmi-1 autoantibody as a new potential biomarker for cervical carcinoma
- Bmi-1 autoantibody in serum as a new potential biomarker of nasopharyngeal carcinoma
- Bmi-1 blocks the TGF-β-mediated senescence
- Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
- Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cells
- Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain
- Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways
- Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes
- Bmi-1 deficiency resulted in developmental defects in mouse teeth and mandibles
- Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
- Bmi-1 downregulates the expression of NF-HEV, a novel cellular protein exhibiting growth suppressive activity
- Bmi-1 enhances the radioresistance of cells by suppressing the expression of NADPH oxidase genes
- Bmi-1 expression as a new independent prognostic marker of hepatocellular carcinoma
- Bmi-1 expression inversely correlates with differentiation but not clinical outcome or CDKN2a expression in Ewing sarcoma family of tumors
- Bmi-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia
- Bmi-1 expression is increased in dogs suffering from immune-mediated haemolytic anaemia
- Bmi-1 expression is inversely correlated with the grading of renal clear cell carcinoma
- Bmi-1 Expression Is Useful To Design Therapy and To Predict Prognosis in Patients with Acute Myeloid Leukemia.
- Bmi-1 expression modulates non-small cell lung cancer progression
- Bmi-1 expression of bone marrow mesenchymal stem cells induced by fluid shear stress mediated with Akt signal molecule
- Bmi-1 expression predicts prognosis in salivary adenoid cystic carcinoma and correlates with epithelial-mesenchymal transition–related factors
- Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
- Bmi-1 Expression Predicts the Progression of Malignant Hematopoietic Stem Cells in Myelodysplastic Syndrome.
- Bmi-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity
- Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-β signaling
- Bmi-1 extends the replicative life span of normal human oral keratinocytes independently of p16INK4A
- Bmi-1 functions as a cooperative oncogene in Ewing’s sarcoma.
- Bmi-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas
- Bmi-1 gene and radiation resistance
- Bmi-1 Gene Expression and Its Significance in 66 Leukemia Patients
- Bmi-1 gene expression and its significance in leukemia
- Bmi-1 gene in regulation of proliferation and survival of human prostate cancer
- Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
- Bmi-1 inhibition by PTC-209 induces mitochondrial apoptosis in acute myeloid leukemia cells
- Bmi-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death
- Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation
- Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal
- Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells
- Bmi-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
- Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells
- Bmi-1 Is Dispensable for the Development of Acute Myeloid Leukemia Mediated by MLL-AF9
- Bmi-1 is essential for the oncogenic potential in CD133+ human laryngeal cancer cells
- Bmi-1 is essential for the tumorigenicity of neuroblastoma cells
- Bmi-1 is highly expressed in M0-subtype acute myeloid leukemia
- Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
- Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells
- Bmi-1 is useful as a novel molecular marker for predicting progression of
- Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis
- Bmi-1 mRNA in plasma from breast cancer patients as possible prognosis marker in advanced pathological stages
- Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo
- Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation
- Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
- Bmi-1 Overexpression in 32Dcl3 Cells Suppresses Granulocytic Differentiation and Ameliorates Their Growth under IL-3 Diminished Conditions.
- Bmi-1 Overexpression Synergizes with p210-BCR-ABL to Induce Stem Cell and Progenitor Transformation.
- Bmi-1 plays a critical role in the protection from acute tubular necrosis by mobilizing renal stem/progenitor cells
- Bmi-1 promotes drug resistance and cellular invasion in head and neck cancer stem cells
- Bmi-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression
- Bmi-1 promotes glioma angiogenesis by activating NF-κB signaling
- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer
- Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence …
- Bmi-1 promotes self-renewal of radio-and temozolomide (TMZ)-resistant breast cancer cells
- Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway
- Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells
- Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin
- Bmi-1 protects human keratinocytes from ionizing radiation by enhancing DNA repair activity and inhibiting the TGF-b signaling
- Bmi-1 Protein Expression in CD34 Positive Acute Myelogenous Leukemia Cells as a Prognostic Factor.
- Bmi-1 reduction plays a key role in physiological and premature aging of primary human keratinocytes
- Bmi-1 Regulates Autoreactive CD4+ T Cell Survival in Immune Thrombocytopenia Patients
- Bmi-1 regulates epithelial-to-mesenchymal transition to promote migration and invasion of breast cancer cells
- Bmi-1 Regulates Ex Vivo Self-Renewal of Human Erythroblasts
- Bmi-1 regulates extensive erythroid self-renewal
- Bmi-1 regulates self-renewal of normal and malignant human mammary stem cells
- Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro
- Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells
- Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs
- Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner
- Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferation
- Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1
- Bmi-1 serves as a potential novel marker for progression in human cutaneous basal cell carcinoma
- Bmi-1 silencing significantly reduces gene expression of DNA damage repair markers in human breast cancer (1047.5)
- Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity
- Bmi-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma
- Bmi-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway
- Bmi-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer
- Bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.
- Bmi-1-Green Fluorescent Protein (GFP)-Knock-In Mice Reveal the Dynamic Regulation of Bmi-1 Expression in Normal and Leukemic Hematopoietic Cells.
- Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels
- Bmi-1-siRNA Regulates the Proliferation of K562 Leukemia Cells in vitro and in vivo by PTEN/pAKT Pathway
- Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases—elevated Bmi-1 expression in late breast cancer relapses
- Bmi-1, stem cells and cancer
- Bmi-1, stem cells and prostate carcinogenesis
- Bmi-1: a protein expressed in stem cells, specialized cells and tumors of the gastrointestinal tract
- Bmi-1: At the crossroads of physiological and pathological biology
- Bmi‐1 expression predicts prognosis for patients with gastric carcinoma
- Bmi‐1 gene is upregulated in early‐stage hepatocellular carcinoma and correlates with ATP‐binding cassette transporter B1 expression
- Bmi‐1 high‐expressing cells enrich cardiac stem/progenitor cells and respond to heart injury
- Bmi‑1 induces radioresistance by suppressing senescence in human U87 glioma cells
- Bmi‐1 is critical for the proliferation and invasiveness of gastric carcinoma cells
- BMI‑1 is important in bufalin‑induced apoptosis of K562 cells
- Bmi‐1 is related to proliferation, survival and poor prognosis in pancreatic cancer
- BMI‐1 Mediates Estrogen‐Deficiency–Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation
- Bmi‐1 plays a critical role in protection from renal tubulointerstitial injury by maintaining redox balance
- Bmi‐1 regulates the migration and invasion of glioma cells through p16
- Bmi‐1‐green fluorescent protein‐knock‐in mice reveal the dynamic regulation of bmi‐1 expression in normal and leukemic hematopoietic cells
- Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway
- BMI‑1, a promising therapeutic target for human cancer
- Cadherin switching, Twist, and Bmi-1 expression at the invasive front correlate with aggressive disease in oral squamous cell carcinoma patients: molecular biology …
- Can the life span of human marrow stromal cells be prolonged by bmi‐1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?
- Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer
- Change of SALL4 and Bmi-1 Expression Levels in Hematologic Malignancies
- Characterization and chromosomal localization of the human proto-oncogene Bmi-1
- Circulating Bmi-1 mRNA as a diagnostic and prognostic biomarker for non-small cell lung cancer
- Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
- Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer
- Clinical implications of Bmi-1 in cancer stem cells of laryngeal carcinoma
- Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
- Clinicopathological and prognostic significance of Bmi‐1 expression in human cervical cancer
- Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) Gene and Protein in …
- Clinicopathological significance of Bmi-1 overexpression in esophageal cancer: a meta-analysis
- Clinicopathological study of Bmi-1 and Mel-18 expression in breast cancer [J]
- Cloning of the rat proto-oncogene Bmi-1
- Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio (chemo) therapy
- Coexpression of Bmi-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin’s disease
- Coexpression of Bmi-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
- Collagen I regulates the self‐renewal of mouse embryonic stem cells through α2β1 integrin‐and DDR1‐dependent Bmi‐1
- Combination of circulating CXCR4 and Bmi-1 mRNA in plasma: A potential novel tumor marker for gastric cancer
- Combination of hTERT and Bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic …
- Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation
- Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the Bmi-1 and ras oncogenes in disease …
- Consistent expression of the stem cell renewal factor BMI‐1 in primary and metastatic melanoma
- Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation.
- Construction of eukaryotic expression vector targeting Bmi-1 and its influences on proliferation of SW480 cells
- Construction of eukaryotic vector Bmi-1 shRNA and its inhibition in Hela cells [J]
- Construction of shRNA-Bmi-1 plasmid and its effect on proliferation of ECA109 cells.
- Construction, identification and expression of recombinant eukaryotic vector pEGFP-Bmi-1
- Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
- Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1
- Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1
- Correlation between Bmi-1 and clinicopathological features of colorectal cancer
- Correlation between Bmi-1, p16 gene expressions and replicative senescence of fetal bone marrow-derived mesenchymal stem cells
- Correlation between Rhoc and Bmi-1 invasiveness and migration and prognostic of esophageal squamous carcinoma
- Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer
- Correlation of HSP70, P53 and Bmi-1 in hepatitis, cirrhosis and hepatocellular carcinoma
- Correlations of Bmi-1 expression and telomerase activity in ovarian cancer tissues
- Correspondence re: S. Beá et al., Bmi-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphomas. Cancer Res …
- Cow’s Milk Yogurt Modulate Expression of STAT5, Bmi-1 and LGR-5 in ileum of Indomethacine-Induced Inflammatory Bowel Disease (IBD) in Rats.
- Crucial Role of the Polycomb Group Gene Product Bmi-1 in the Maintenance of Self-Renewing Hematopoietic Stem Cells
- Defects in mesenchymal stem cell self‐renewal and cell fate determination lead to an osteopenic phenotype in Bmi‐1 null mice
- Deletion of Bmi-1 gene leads to skin aging in mice [J]
- Depletion of Bmi-1 enhances 5-fluorouracil-induced apoptosis and autophagy in hepatocellular carcinoma cells
- Deregulation of Bmi-1 is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma
- Detection of CD133, Bmi‐1, and ABCG2 in ameloblastic tumors
- Detection of circulating Bmi‐1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer
- Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers
- Diagnostic value of combined detection of autoantibodies against p53 and Bmi-1 in lung cancer
- Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma
- DIPG-13. SENSITIVITY OF DIPG CELLS TO Bmi-1 MODULATOR PTC596 IS INDEPENDENT OF EZH2 ACTIVITY
- DIPG-18. VALIDATION OF Bmi-1 AS A THERAPEUTIC TARGET IN DIFFUSE INTRINSIC PONTINE GLIOMA
- Direct serum assay for cell-free Bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer
- Distinct Bmi-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation
- Doublecortin-like kinase 1 (DCLK1) regulates B cell-specific moloney murine leukemia virus insertion site 1 (Bmi-1) and is associated with metastasis and prognosis …
- Down-regulation of Bmi-1 by RNA interference in Jurkat cells
- Down-Regulation of Bmi-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.
- Down‐regulation of BMI‐1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells
- Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer
- Downregulation of Bmi-1 By the Small Molecule PTC596 Induces Mitochondrial Apoptosis in Mantle Cell Lymphoma
- Downregulation of Bmi-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells
- Downregulation of Bmi-1 enhances chemosensitivity in breast cancer cells.
- Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44+ nasopharyngeal carcinoma cancer stem-like cells
- Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma
- Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/Bmi-1 signaling
- Downregulation of miR-221,-30d, and-15a contributes to pathogenesis of prostate cancer by targeting Bmi-1
- Drosophila genes Posterior Sex Combs and Suppressor two of zeste encode proteins with homology to the murine Bmi-1 oncogene
- Effect and mechanism of pyrroloquinoline quinone on anti-osteoporosis in Bmi-1 knockout mice-Anti-oxidant effect of pyrroloquinoline quinone
- Effect of 5-fluorouracil on the expression of Oct4 and Bmi-1 in human breast cancer cell line MCF7
- Effect of 5-FU on expression of Bmi-1, Sca-1 and Oct-4 in human breast cancer cell line MDA-MB-468
- Effect of Bmi-1 gene overexpression on proliferation of human gastric mucosal epithelial cell line GES-1 [J]
- Effect of Bmi-1 on radiosensitization of esophageal carcino-ma cells after silencing of Bmi-1 gene
- Effect of Bmi-1-mediated NF-κB signaling pathway on the stem-like properties of CD133+ human liver cancer cells
- Effect of gene silencing of Bmi-1 on proliferation regulation of CD44+ nasopharyngeal carcinoma cancer stem-like cells
- Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells
- Effect of silencing Bmi-1 by RNA interference on function of K562 cell line
- Effect of silencing Bmi-1 expression in reversing cisplatin resistance in lung cancer cells and its mechanism
- Effect of siRNA-mediated silencing Bmi-1 gene expression on the proliferation of lung cancer cell line A549 in vitro and in vivo
- Effect of siRNA-mediated silencing Bmi-1 gene expression on the proliferation of lung cancer cell line A549 in vitro and in vivo
- Effect of siRNA‐mediated silencing of Bmi‐1 gene expression on HeLa cells
- Effects of antisense Bmi-1 RNA on the proliferation of lung cancer cell line A549
- Effects of Bmi-1 gene suppression on nasopharyngeal carcinoma cell biology behavior
- Effects of Bmi-1 on progression of human glioma SNB19 cells [J]
- Effects of Bmi-1 over-expression on HOX family expression and cell cycle in HeLa cells
- Effects of Bmi-1 RNAi gene on laryngeal carcinoma Hep-2 cells
- Effects of Bmi-1 RNAi gene on laryngeal carcinoma Hep-2 cells [J]
- Effects of Bmi-1-siRNA on proliferation of lung adenocarcinoma SPC-A1 cells and its mechanism
- Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells
- Effects of RNA interfering Bmi-1 on glioma cells proliferation
- Effects of siRNA silencing of Bmi-1 expression on proliferation of Hela cells
- Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells
- Efficient immortalization of primary human cells by p16INK4a‐specific short hairpin RNA or Bmi‐1, combined with introduction of hTERT
- Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
- Elevated Serum IL-6, IL-8, Monocyte Chemoattractant Protein-1, CRP, and IFN-Levels in 10-to 11-Year-Old Boys with Increased BMI
- Enforced Expression of Bmi-1 in Postnatal Human CD34+ Cells Promotes Erythroid Differentiation
- Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1
- Enhanced Self-Renewal of Hematopoietic Stem Cells Mediated by the Polycomb Gene Product, Bmi-1.
- Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer
- Establishment of a U266 cell line with stable Bmi-1 silencing by lentivirus-mediated RNA interference
- Establishment of detection method for serum circulating Bmi-1 mRNA and its application in diagnosis of colorectal cancer
- EVALUATING THE EXPRESSION OF Bmi-1, AS A NEW MOLECULAR MARKER IN DIAGNOSIS AND CHISSIFICATION OF BLADDER TUMORS
- Evaluating the expression of Bmi-1, as a new molecular marker in diagnosis and classification of bladder tumors
- Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of Bmi-1 function in ovarian cancer
- Evaluation of potential prognostic value of Bmi-1 gene product and selected markers of proliferation (Ki-67) and apoptosis (p53) in the neuroblastoma group of …
- Evaluation of the expression of Bmi-1 stem cell marker in sinonasal melanomas and its correlation with the expression of cell cycle proteins
- Ewing tumors that do not over-express Bmi-1 are a distinct molecular subclass with variant biology: A report from the Children’s Oncology Group
- Ewing tumors that do not overexpress Bmi-1 are a distinct molecular subclass with variant biology: a report from the Children’s Oncology Group
- Ex-Vivo Expansion of Human Cord Blood CD34+ Cells by Overexpression of Bmi-1.
- Exacerbation of acute leukemia bearing isolated i (17q) along with proliferation of blasts with high Bmi-1 expression
- Expression and associations of TRAF1, Bmi-1, ALDH1, and Lin28B in oral squamous cell carcinoma
- Expression and Clinical Significance of Bmi-1 and P14 in Extranodal NK/T-cell Lymphoma
- Expression and clinical significance of Bmi-1 in colorectal cancer
- Expression and clinical significance of Bmi-1 in gastric carcinoma
- Expression and Clinical Significance of Bmi-1 in Rectal Cancer
- Expression and Clinical Significance of Bmi-1 Oncogene and Its Protein in Cervical Cancer
- Expression and Clinical Significance of Bmi-1 Oncogene in Breast Cancer
- Expression and Clinical Significance of Bmi-1 Oncogene in Gastric Carcinoma
- Expression and clinical significance of Bmi-1 protein and hTERT protein in non-small cell lung cancer.
- Expression and clinical significance of Bmi-1, Caspase-8 protein in primary epithelia ovarian cancer
- Expression and clinical significance of Bmi-1, Caspase-8 protein in primary epithelia ovarian cancer [J]
- Expression and clinical significance of Bmi-1, cyclin D1 and p16 in gastric carcinoma [J]
- Expression and clinical significance of Bmi-1, Mdm2 and Ki-67 in extrahepatic biliary duct carcinoma.
- Expression and clinical significance of Bmi-1, Podoplanin and p53 in human thymic epithelial tumor
- Expression and clinical significance of Bmi-1, Podoplanin and p53 in human thymic epithelial tumor [J]
- Expression and clinicopathological significance of Mel-18 and Bmi-1 in esophageal squamous cell carcinoma
- Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma
- Expression and distribution patterns of the stem cell marker, nestin, and the stem cell renewal factor, Bmi-1, in normal human nasal mucosa and nasal polyps
- Expression and significance of Bmi 1 in pancreatic carcinoma
- Expression and significance of Bmi-1 and P16 in colorectal carcinoma patients.
- Expression and significance of Bmi-1 and P16 in colorectal carcinoma.
- Expression and Significance of Bmi-1 and PCNA in Cutaneous Squamous Cell Carcinoma
- Expression and significance of Bmi-1 in breast cancer
- Expression and Significance of Bmi-1 in Cervical Cancer
- Expression and significance of Bmi-1 in endometrial carcinoma
- Expression and significance of Bmi-1 in hepatocellular carcinoma tissue and portal vein tumor thrombus
- Expression and significance of Bmi-1 in human colon carcinoma [J]
- Expression and significance of Bmi-1 mRNA in acute myeloid leukemia with real-time fluorescent quantitative polymerase chain reaction
- Expression and significance of Notch1 and Bmi-1 protein in lung cancer tissue
- Expression and significance of the Bmi-1 gene in hepatocellular carcinoma
- Expression and significances of Bmi-1 and c-myc in diffuse large B-cell lymphoma
- Expression changes in EZH2, but not in Bmi-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer
- Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer
- Expression of an alternate splice form of Bmi-1 in multiple myeloma
- Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (Bmi-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver …
- Expression of Bmi-1 and EZH2 in tissues adjacent to human epithelial ovarian cancer cells of orthotopic implantation in nude mice
- Expression of Bmi-1 and hTERT in breast cancer cell line MDA-MB-468 and their relationship with apoptosis [J]
- Expression of Bmi-1 and Mel-18 in breast tissue-a diagnostic marker in patients with breast cancer
- Expression of Bmi-1 and p16 gene in transitional cell carcinoma of bladder
- Expression of Bmi-1 and p16 in cervical carcinoma carcinogenesis progression and its significance [J]
- Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma
- Expression of Bmi-1 Gene in Children with Acute Leukemia and Its Clinical Significance
- Expression of Bmi-1 Gene in Children with Acute Leukemia and Its Clinical Significance [J]
- Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and its effect on cell cycle, apoptosis and migration
- Expression of Bmi-1 gene in papillary thyroid carcinoma
- Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis
- Expression of Bmi-1 in gastric cancer and its clinical significance
- Expression of Bmi-1 in gastric cancer and its significance [J]
- Expression of Bmi-1 in NSCLC and Its Relationship to Clinicopathologic Characters
- Expression of Bmi-1 in pediatric brain tumors as a new independent prognostic marker of patient survival
- Expression of Bmi-1 is a prognostic marker in bladder cancer
- Expression of Bmi-1 Protein in Esophageal Squamous Cell Carcinoma Tissue and Its Relationship with Invasion and Metastasis
- Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients
- Expression of Bmi-1 Stem Cell Marker and P16 in Sinonasal Melanoma and Its Correlation with Cellular Proliferation
- Expression of Bmi-1 Stem Cell Marker and P16 in Sinonasal Melanoma and Its Correlation with Cellular Proliferation
- Expression of Bmi-1, p14 ARF and Mdm2 and their clinical significance in colorectal carcinoma
- Expression of Bmi-1, P16, and CD44v6 in uterine cervical carcinoma and its clinical significance
- Expression of BMI‐1 in normal skin and inflammatory and neoplastic skin lesions
- Expression of c-myc, Bmi-1, serum insulin-like growth factor-Ⅰ and insulin-like growth factor binding protein-3 and their significances in diffuse large B-cell lymphoma
- Expression of CD44, CD44v9, ABCG2, CD24, Bmi‑1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological …
- EXPRESSION OF OCT-4, SOX-2, NANOG, NUCLEOSTEMIN, Bmi-1 AND SOX-9 SELF RENEWAL GENES IN HUMAN UMBILICAL CORD VEIN MESENCHYMAL …
- Expression of p120 catenin and Bmi-1 and their clinical significance in invasive mammary ductal carcinoma
- Expression of Polycomb Group Proteins EZH2 and Bmi-1 During Progression of Esophageal Squamous Intraepithelial Neoplasia
- Expression of polycomb protein BMI‐1 maintains the plasticity of basal bronchial epithelial cells
- Expression of Polycomb-group (PcG) protein Bmi-1 predicts prognosis in patients with acute myeloid leukemia
- Expression of Proteins P16INK 4a, P53 and Bmi-1 in Hematopoietic Stem Cells of Patients with MDS. the Role of Cellular Senescence.
- Expression of SALL4 and Bmi-1 mRNA in acute leukemia
- Expression of stemness gene Bmi-1 in hepatocellular carcinoma
- Expression of the p16INK4a gene product, methylation of the p16INK4a promoter region and expression of the polycomb-group gene Bmi-1 in squamous cell lung …
- Expression of the polycomb group gene Bmi-1 in the early chick embryo
- Expression Of The Stem Cell Markers ABCG2/BCRP, Bmi-1, P63alpha And C/EBPdelta In The Normal Human Cornea: An Immunohistochemical Study
- Expression of VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma
- Expression patterns of ABCG2, Bmi-1, Oct-3/4, and Yap in the developing mouse incisor
- Expression patterns of Bmi‐1 and p16 significantly correlate with overall, disease‐specific, and recurrence‐free survival in oropharyngeal squamous cell carcinoma
- Expression patterns of USP22 and potential targets Bmi-1, PTEN, p-AKT in non-small-cell lung cancer
- Expressions and clinical significances of Bmi-1 in human cervical carcinoma [J]
- Expressions and clinicopathological significances of Bmi-1 and PADI4 in esophageal squamous cell car-cinoma
- EXPRESSIONS OF Bmi-1 AND C-myc PROTEINS IN NON-SMALL CELL LUNG CANCER AND THEIR CORRELATION [J]
- EXPRESSIONS OF Bmi-1 AND hTERT PROTEIN IN GASTRIC CARCINOMA
- Expressions of Bmi-1 and p53 and significance in colon cancer
- EXTH-27. VALIDATION OF Bmi-1 AS A THERAPEUTIC TARGET IN DIFFUSE INTRINSIC PONTINE GLIOMA
- EZH2-mediated, but not Bmi-1, epigenetic alteration may be associated with the accelerated cell proliferation and malignant step in IPMN.
- flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes Bmi-1.
- FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression
- FoxM1c counteracts oxidative stress-induced senescence in mouse embryonic fibroblasts by up-regulation of Bmi-1 expression
- Fuel shipment experience, fuel movements from the Bmi-1 transport cask
- Glucagon-like peptide-2 requires a full complement of Bmi-1 for its proliferative effects in the murine small intestine
- Harnessing the power of stem cell self-renewal pathways in cancer: Dissecting the role of Bmi-1 in Ewing’s sarcoma initiation and maintenance
- HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression
- Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
- HER 2 NEU and Bmi 1 gene expression in Invasive Ductal Carcinoma Breast and Its correlation with hormone receptors and other known prognostic factors
- Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer
- Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging
- High peritumoral Bmi-1 expression is an independent prognosticator of poor prognosis in renal cell carcinoma
- Id1 and NF-κB promote the generation of CD133+ and Bmi-1+ keratinocytes and the growth of xenograft tumors in mice
- Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex
- Identification and characterization of Bmi-1-responding element within the human p16 promoter
- Identification of a polymorphism in the RING finger of human Bmi-1 that causes its degradation by the ubiquitin–proteasome system
- Identification Of Bmi-1 As A Prognostic Marker For Differentiation And Invasiveness Of Retinoblastomas
- Identification of genes differentially regulated by E6 in human oral keratinocytes expressing exogenous Bmi-1
- IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance
- Immortalization of cementoblast progenitor cells with Bmi‐1 and TERT
- Immortalization of human oral keratinocytes by Bmi-1 and HPV type 16 E6 requires telomerase activation domain of E6
- Immortalized Human Placenta Derived Mesenchymal Cells by Transfection with Bmi-1 Lost the Abilitiy To Differencitate into Cell Types of Osteocytic, Condoricytic and …
- Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer
- Immunohistochemical expression of Bmi-1, S100A4, and claudin-1 in breast cancer
- Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi‐1 in basal cell carcinoma
- Impaired GLP-1 response predicts prediabetes in obese PCOS with adverse metabolic phenotype independent of BMI
- Impaired odontogenic differentiation of senescent dental mesenchymal stem cells is associated with loss of Bmi-1 expression
- Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas
- Implication of USP22 in the regulation of Bmi-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas
- In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to Bmi-1 Protein Correlate with Higher Expression of Bmi-1 in Leukemia Progenitors, and May Contribute to …
- In vitro study of joint intervention of E-cad and Bmi-1 mediated by transcription activator-like effector nuclease in nasopharyngeal carcinoma
- Increased expression of the EZH2 polycomb group gene in Bmi-1-positive neoplastic cells during bronchial carcinogenesis
- Increased global long interspersed nucleotide element 1 DNA methylation in type 2 diabetes mellitus individuals relates to lower blood pressure and BMI
- Increased levels of circulating and tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC patients: potential tool for minimally invasive cancer diagnosis
- Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma
- Independent prognostic value of the basal‐like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI‐1
- Inhibiting effect of small interfering RNA of Bmi-1 on the proliferation of breast cancer MCF-7 cells in vitro [J]
- Inhibition effect of antisense Bmi-1 on Jurkat cells
- Inhibition of Bmi-1 suppressed the tumorigenicity of oral cancer-derived ALDH1-positive cells
- Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1
- Inhibitory Effect of Bmi-1 Knockdown on Growth of Human SO-RB_ (50) Cells In Vitro [J]
- Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma
- Interaction of hedgehog and notch pathways, and Bmi-1 in the regulation of human breast stem cell self-renewal
- Intracellular redox status determines self-renewal activity of breast cancer stem-like cells through activation of Nrf2-mediated FoxO3a-Bmi-1 signaling
- Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor …
- Investigating the role of Bmi-1 in liver growth and function
- Investigating the roles of Bmi-1 and IGF-1 in promoting ESFT survival
- Investigation of the Correlation Between the Expression and Pathological Eharaeteristies of Bmi-1 Protein in Breast Cancer
- Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16Ink4A/p14ARF gene expressions: An in vivo and in vitro study
- Knock-down of Bmi-1 Arrests HeLa Cells in G_1 Phase
- Knockdown of Bmi-1 causes cell-cycle arrest and derepresses p16INK4a, HOXA9 and HOXC13 mRNA expression in HeLa cells
- Knockdown of Bmi-1 impairs growth and invasiveness of human gastric carcinoma cells
- Knockdown of long noncoding RNA CCAT1 inhibits cell growth, invasion and peritoneal metastasis via downregulation of Bmi-1 in gastric cancer.
- Knockdown of the Bmi-1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast …
- Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability
- Loss of Bmi-1 expression is associated with clinical progress of malignant melanoma
- Loss of BMI‐1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD‐2/MyD88‐mediated NF‐κB signaling
- Loss of T cell receptor-induced Bmi-1 in the KLRG1+ senescent CD8+ T lymphocyte
- Low Bmi-1 expression is associated with an activated Bmi-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma
- Lower Bmi-1 expression may predict longer survival of Colon Cancer patients
- Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells
- Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins
- Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation
- Microarray analysis of Bmi-1 downstream genes in normal human oral keratinocytes.
- MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence
- MicroRNA-128 increases glioma cell radio-sensitivity by suppressing senescent evasion through oncogene Bmi-1
- MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and Bmi-1 in cancer stem cells
- MicroRNA-128 suppresses prostate cancer by inhibiting Bmi-1
- MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1
- MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1
- microRNA-186 Suppresses Neural Stem Cell Self-Renewal by Modulating Bmi-1/FOXG1/FOXO3 Network
- MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene Bmi-1
- MicroRNA-200c inhibits epithelial-mesenchymal transition by targeting the Bmi-1 gene through the phospho-AKT pathway in endometrial carcinoma cells in …
- MicroRNA-203 increases cell radiosensitivity via directly targeting Bmi-1 in hepatocellular carcinoma
- MicroRNA-203 induces apoptosis by targeting Bmi-1 in YD-38 oral cancer cells
- MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting Bmi-1
- MicroRNA-320a protects against osteoarthritis cartilage degeneration by regulating the expressions of Bmi-1 and RUNX2 in chondrocytes
- MicroRNA-330-3p expression indicates good prognosis and suppresses cell proliferation by targeting Bmi-1 in osteosarcoma
- MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation
- MicroRNA‑183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi‑1
- MicroRNA‑200c suppresses cell growth and metastasis by targeting Bmi‑1 and E2F3 in renal cancer cells
- MicroRNA‐320a inhibits cell proliferation, migration and invasion by targeting BMI‐1 in nasopharyngeal carcinoma
- MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer
- miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression
- miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
- miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of Bmi-1 and E2F3
- miR-200c inhibits melanoma progression and drug resistance through down-regulation of Bmi-1
